ADRIAMYCIN

Brand name authorized in: Australia New Zealand Singapore United States

Active ingredients

The drug ADRIAMYCIN contains one active pharmaceutical ingredient (API):

1 Doxorubicin
UNII 82F2G7BL4E - DOXORUBICIN HYDROCHLORIDE

Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects.

Read about Doxorubicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
L01DB01
Doxorubicin
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB01

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
ADRIAMYCIN Solution for injection
Structured Product Labeling (SPL/PLR)
US

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 4361M, 7229L
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 2203
SG
Health Sciences Authority
Identifier(s): 10566P
US
FDA, National Drug Code
Identifier(s): 0143-9275, 0143-9277, 0143-9369, 0143-9370, 0143-9371, 0143-9372, 0143-9546, 0143-9547, 0143-9548, 0143-9549